Russia claims promising signs in early trials of antiviral drug favipiravir
Reuters India -

A candidate drug for treating the new coronavirus, favipiravir, has produced promising results in early clinical trials in Russia, according to the Russian Direct Investment Fund, which provided 150 million roubles ($2 million) in funding for the project.

Read this story at , ,


Related Articles